Back to Top
Go Back
Journal Photo for Neuro-Oncology Advances
Peer reviewed only Open Access

Neuro-Oncology Advances (NOA)

Publisher : Oxford University Press
Pathology Clinical medicine Neuro-Oncology
e-ISSN 2632-2498
Issue Frequency Monthly
Impact Factor 3.9
Est. Year 2019
Mobile 4401865556767
DOI YES
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email jnls.cust.serv@oup.com

Journal Descriptions

Neuro-Oncology Advances is intended to expand the scope and spectrum of what Neuro-Oncology journal covers. NOA is an open access inter-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neuroradiologists, and researchers together with educators. NOA will be publishing high-quality research after the same exceptional-standards of peer-review and editorial process that the field receives from Neuro-Oncology; however, NOA may not always apply the same criteria for novelty that may be a factor in acceptance decisions for Neuro-Oncology. NOA will serve to increase accessibility to areas of research outside of the scope of Neuro-Oncology. NOA aims to publish research from all disciplines that are interested in advancing outcomes of brain, spine and peripheral nerve tumors. It focuses to capture investigative advances in areas that have traditionally fallen outside of Neuro-Oncology. The following broad priorities will encompass clinical, investigative and basic science research, bioinformatics and computational science analysis, clinical and surgical trials, technology and engineering.

Neuro-Oncology Advances (NOA) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Pathology, Clinical medicine, Neuro-Oncology, Surgical trials, Neurology, Surgery , Online , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2632-2498, Established: 2019, Impact Factor: 3.9
  • Provides Crossref DOI
  • Indexed in: DOAJ

  • Not indexed in Scopus, WoS, PubMed, UGC CARE

Indexing